Phaseline

Targets › ATP5F1A

ATP5F1A (ATP synthase F(1) complex subunit alpha, mitochondrial): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Infectious disease; next expected readout Feb 2027.

Subunit alpha, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel. (UniProt, P25705)

Open in Phaseline: the race on ATP5F1A, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Global Alliance for TB Drug DevelopmentBedaquiline
ATP synthase inhibitor
ATP5F1APhase 2Pulmonary TBFeb 2027

Conditions

Pulmonary TB (1)

Modalities

small molecule (1)

Companies

Global Alliance for TB Drug Development (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.